WebJul 1, 2024 · Auryxia is a phosphate binder used for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. Auryxia is an iron replacement product used for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis. Pediatric Use: The safety and efficacy of Auryxia have not been … WebAuryxia (ferric citrate) only works when it's taken with meals. It binds to the phosphorus in your food, so if you take it on an empty stomach, there's no food for it to bind to. If you …
How AURYXIA Works AURYXIA® (ferric citrate) HP
WebDec 12, 2024 · Auryxia 210 mg ferric iron tablets for oral administration, equivalent to 1g ferric citrate, are film-coated, peach-colored, and oval-shaped tablets debossed with “KX52.” The inactive ingredients are pregelatinized starch and calcium stearate. WebMar 25, 2024 · Summary. Auryxia (ferric citrate) is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Common side effects of Auryxia include diarrhea, nausea, constipation, vomiting, cough, and dark stools (related to the iron content). howells point
Mechanism of Action and Clinical Attributes of Auryxia
WebNov 7, 2024 · About Auryxia® (ferric citrate) tablets. Auryxia (ferric citrate) was approved by the U.S. Food and Drug Administration on September 5, 2014 for the control of serum phosphorus levels in adults ... WebAuryxia ® (ferric citrate; Keryx Biopharmaceuticals, Inc., Boston, MA, USA) is an iron-based compound with distinctive chemical characteristics and a mechanism of action that render it dually effective as a therapy in patients with CKD; it has been approved as a phosphate binder for the control of serum phosphate levels in adult CKD patients … WebMay 9, 2024 · CAMBRIDGE, Mass., May 9, 2024/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced financial results for the first quarter ended March 31, 2024and provided business updates. howells pharmacy southend